New article: We used a versatile bacterial protein that self-assembles into 60-mer nanoparticles to design immunogenic SARS-CoV-2 vaccines with neutralizing activity against multiple variants.
📣 We would like to share the newly published article "Systemic and Mucosal Humoral Immune Responses to Lumazine Synthase 60-mer Nanoparticle SARS-CoV-2 Vaccines"
👉 To read the full article access for free here: https://t.co/4dEku2ttBp
Join me live on CNN this Sunday, Dec 10th, 8 pm EST for the All-Star tribute! Honored to share our journey of making healthcare accessible in underserved communities. Your cheers and comments may be seen on-air during CNN Heroes: An All-Star Tribute. Let's celebrate together!
It is so important to expose students as early as possible to STEM careers, and give them the tools to become successful in the future.
My advice to the HS students today was “take advantage of these programs, take advantage of mentorship, and learn to develop your soft skills”
🗣️NEW Research: A first-in-human phase 1 trial of an HIV-1 vaccine in healthy adults @NIH @NIAIDNews
“Trimer 4571 was safe, well tolerated, and immunogenic in this first-in-human trial” #HIV#Vaccine
Read more: https://t.co/0EeikXqjIM
#RareDiseaseDay at @NIH 2022 will feature discussions on diversity in #RareDiseases research, the development of individualized therapies, the use of telehealth during the #COVID19 pandemic and more!
Check out the agenda today: https://t.co/TkIpQqJqGz
#RDDNIH
Honored to be one of the recipients of this award as a member of the Advancing COVID-19 Vaccines: ACTIV and HHS Collaborations team “For outstanding efforts in the pursuit of efficacious vaccines to prevent COVID-19.”
Please join us in congratulating the 2021 NIH Director’s Awards recipients. These individuals are being recognized for their outstanding contributions to support the mission of the National Institutes of Health. To browse the 2021 recipient list, visit https://t.co/Ba77sSuaM6
Just published @nature: Memory B cells to #SARSCoV2 from 87 infectees persist >6 months, evolve, more potent than original antibodies, likely more resistant to "escape" spike mutations, antigen persistence in gut in 7/14 biopsied https://t.co/ImuoZdfzJO
@c_gaebler@NussenzweigL
@garyalsmith About 80% recovery rate. It’d be great if the numbers are true. However, If these numbers are fudged, the virus can’t be fudged so we’ll see sooner or later. But I really hope the numbers are accurate.
First time in a hospital since being pulled from rotations.
I’m anxious and can feel every heartbeat. My mask covers half of my face, but it’s not enough.
Why am I anxious? It’s not the virus. And it’s not the usual feelings of #medstudent inadequacy. This is why #icantbreathe:
@qwobbyclint @lanstyan @moigovgh @konkrumah Determining efficacy means testing if this treatment will produce the desired results as speculated. You can’t just blindly take someone’s word for it. You need to confirm it. That is how the world of medicine works, and the reason why FDA exists.